[Immunomodulating therapy of a suppurative infection of the soft tissues].
The initial immunological status in patients with purulent infection of the soft tissues is characterized by T-cell deficiency and relative hyperfunction of the B-immunity. The risk group with Grade 2-3T-cell immune deficiency takes up 44.5-77.5% and is encountered in patients with the B blood group and positive Rh factor in 79.1 +/- 5.2 and 70.8 +/- 4.3% of cases, respectively. Combination of sodium nucleinate and autohemotransfusion with the traditional therapy raises its efficacy. This is attended by correction of immunological disorders in T-cells and phagocytes, facilitates cleansing of the foci and increase of antibiotic sensitivity of the flora, and shortens the term of treatment.
Bobrova
N V
NV
Zemskov
A M
AM
Vysotskaia
A T
AT
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000628:therapy*; D001804:Blood Transfusion, Autologous; D003240:Connective Tissue Diseases / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009696:Nucleic Acids / Q000627:therapeutic use*; D013492:Suppuration
D000276:Adjuvants, Immunologic; D009696:Nucleic Acids; C013683:sodium nucleinate
Immunokorrigiruiushchaia terapiia gnoĭnoĭ infektsii miagkikh tkaneĭ.